PIII Begin Period Cash Flow from 2010 to 2024
| PIII Stock | USD 0.24 0.03 14.29% |
Begin Period Cash Flow | First Reported 2010-12-31 | Previous Quarter 18.5 M | Current Value 17.4 M | Quarterly Volatility 12.7 M |
Check P3 Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among P3 Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 91 M, Interest Expense of 16.8 M or Selling General Administrative of 87.6 M, as well as many indicators such as Price To Sales Ratio of 0.0932, Dividend Yield of 0.0 or PTB Ratio of 0.83. PIII financial statements analysis is a perfect complement when working with P3 Health Valuation or Volatility modules.
PIII | Begin Period Cash Flow |
Latest P3 Health's Begin Period Cash Flow Growth Pattern
Below is the plot of the Begin Period Cash Flow of P3 Health Partners over the last few years. It is the amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. P3 Health's Begin Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in P3 Health's overall financial position and show how it may be relating to other accounts over time.
| Begin Period Cash Flow | 10 Years Trend |
|
Begin Period Cash Flow |
| Timeline |
PIII Begin Period Cash Flow Regression Statistics
| Arithmetic Mean | 8,556,339 | |
| Geometric Mean | 3,242,899 | |
| Coefficient Of Variation | 148.44 | |
| Mean Deviation | 9,923,758 | |
| Median | 2,013,579 | |
| Standard Deviation | 12,700,929 | |
| Sample Variance | 161.3T | |
| Range | 39.8M | |
| R-Value | 0.55 | |
| Mean Square Error | 120.5T | |
| R-Squared | 0.31 | |
| Significance | 0.03 | |
| Slope | 1,571,372 | |
| Total Sum of Squares | 2258.4T |
PIII Begin Period Cash Flow History
About P3 Health Financial Statements
Investors use fundamental indicators, such as P3 Health's Begin Period Cash Flow, to determine how well the company is positioned to perform in the future. Although P3 Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Begin Period Cash Flow | 18.5 M | 17.4 M |
Currently Active Assets on Macroaxis
When determining whether P3 Health Partners is a strong investment it is important to analyze P3 Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact P3 Health's future performance. For an informed investment choice regarding PIII Stock, refer to the following important reports:Check out the analysis of P3 Health Correlation against competitors. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of P3 Health. If investors know PIII will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about P3 Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.86) | Revenue Per Share 11.552 | Quarterly Revenue Growth 0.152 | Return On Assets (0.12) | Return On Equity (0.41) |
The market value of P3 Health Partners is measured differently than its book value, which is the value of PIII that is recorded on the company's balance sheet. Investors also form their own opinion of P3 Health's value that differs from its market value or its book value, called intrinsic value, which is P3 Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because P3 Health's market value can be influenced by many factors that don't directly affect P3 Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between P3 Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if P3 Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, P3 Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.